Matches in SemOpenAlex for { <https://semopenalex.org/work/W4243363455> ?p ?o ?g. }
Showing items 1 to 82 of
82
with 100 items per page.
- W4243363455 endingPage "66" @default.
- W4243363455 startingPage "61" @default.
- W4243363455 abstract "Indapamide will soon be marketed in the United States as an oral antihypertensive agent and diuretic. Its molecular structure includes both a polar sulfamoyl chlorobenzamide moiety and a lipid-soluble methylindoline molety. It differs chemically from the thiazides in that it does not possess the thiazide ring system and it contains only one sulfonamide group. Indapamide is rapidly and well absorbed after oral Ingestion, and it has a long terminal half-life in whole blood which permits once daily administration. Indapamide is extensively metabolized by the liver with excretion of unchanged drug accounting for approximately 5% of the total dose. Although indapamide is thought to exert its antihypertensive effect by its diuretic action, several investigations employing laboratory animal preparations have documented a direct vascular action. It has been categorized as a calcium channel blocking agent and this may account for a portion of its antihypertensive effectiveness. In both the treatment of edema and as an antihypertensive agent, indapamide appears to be comparable to hydrochlorothiazide, chlorthalidone and furosemide and seems to have no clinically important advantage over these agents. Side effects associated with indapamide are minimal and appear to be comparable to those observed with other antihypertensive diuretics. Based on few published studies, indapamide appears to be a useful long acting antihypertensive and diuretic agent that is well tolerated and associated with minimal biochemical abnormalities or side effects." @default.
- W4243363455 created "2022-05-12" @default.
- W4243363455 creator A5074437894 @default.
- W4243363455 date "1983-03-04" @default.
- W4243363455 modified "2023-09-25" @default.
- W4243363455 title "Indapamide: Clinical Pharmacology, Therapeutic Efficacy in Hypertension, and Adverse Effects" @default.
- W4243363455 cites W107478625 @default.
- W4243363455 cites W1465551735 @default.
- W4243363455 cites W1971676288 @default.
- W4243363455 cites W1972851974 @default.
- W4243363455 cites W1978786101 @default.
- W4243363455 cites W1989296071 @default.
- W4243363455 cites W1996796059 @default.
- W4243363455 cites W2008100151 @default.
- W4243363455 cites W2019609170 @default.
- W4243363455 cites W2028462946 @default.
- W4243363455 cites W2038406921 @default.
- W4243363455 cites W2050194153 @default.
- W4243363455 cites W2058185586 @default.
- W4243363455 cites W2059421141 @default.
- W4243363455 cites W2071797203 @default.
- W4243363455 cites W2086528583 @default.
- W4243363455 cites W2087914813 @default.
- W4243363455 cites W2089002932 @default.
- W4243363455 cites W2097261606 @default.
- W4243363455 cites W2122713834 @default.
- W4243363455 cites W2137621026 @default.
- W4243363455 cites W2141483250 @default.
- W4243363455 cites W2145369400 @default.
- W4243363455 cites W2162910776 @default.
- W4243363455 cites W2169067200 @default.
- W4243363455 cites W2402341309 @default.
- W4243363455 cites W2518130545 @default.
- W4243363455 doi "https://doi.org/10.1002/j.1875-9114.1983.tb04535.x" @default.
- W4243363455 hasPublicationYear "1983" @default.
- W4243363455 type Work @default.
- W4243363455 citedByCount "2" @default.
- W4243363455 countsByYear W42433634552015 @default.
- W4243363455 crossrefType "journal-article" @default.
- W4243363455 hasAuthorship W4243363455A5074437894 @default.
- W4243363455 hasConcept C126322002 @default.
- W4243363455 hasConcept C2777622974 @default.
- W4243363455 hasConcept C2777748223 @default.
- W4243363455 hasConcept C2777955127 @default.
- W4243363455 hasConcept C2779918671 @default.
- W4243363455 hasConcept C2780361556 @default.
- W4243363455 hasConcept C2780427769 @default.
- W4243363455 hasConcept C2780437262 @default.
- W4243363455 hasConcept C71924100 @default.
- W4243363455 hasConcept C84393581 @default.
- W4243363455 hasConcept C98274493 @default.
- W4243363455 hasConceptScore W4243363455C126322002 @default.
- W4243363455 hasConceptScore W4243363455C2777622974 @default.
- W4243363455 hasConceptScore W4243363455C2777748223 @default.
- W4243363455 hasConceptScore W4243363455C2777955127 @default.
- W4243363455 hasConceptScore W4243363455C2779918671 @default.
- W4243363455 hasConceptScore W4243363455C2780361556 @default.
- W4243363455 hasConceptScore W4243363455C2780427769 @default.
- W4243363455 hasConceptScore W4243363455C2780437262 @default.
- W4243363455 hasConceptScore W4243363455C71924100 @default.
- W4243363455 hasConceptScore W4243363455C84393581 @default.
- W4243363455 hasConceptScore W4243363455C98274493 @default.
- W4243363455 hasIssue "2" @default.
- W4243363455 hasLocation W42433634551 @default.
- W4243363455 hasOpenAccess W4243363455 @default.
- W4243363455 hasPrimaryLocation W42433634551 @default.
- W4243363455 hasRelatedWork W1952223593 @default.
- W4243363455 hasRelatedWork W2059185450 @default.
- W4243363455 hasRelatedWork W2074929604 @default.
- W4243363455 hasRelatedWork W2108354142 @default.
- W4243363455 hasRelatedWork W2397412071 @default.
- W4243363455 hasRelatedWork W2404734884 @default.
- W4243363455 hasRelatedWork W2475345624 @default.
- W4243363455 hasRelatedWork W4205171540 @default.
- W4243363455 hasRelatedWork W4243363455 @default.
- W4243363455 hasRelatedWork W4253976322 @default.
- W4243363455 hasVolume "3" @default.
- W4243363455 isParatext "false" @default.
- W4243363455 isRetracted "false" @default.
- W4243363455 workType "article" @default.